The global intellectual property landscape of induced pluripotent stem cell technologies. (Q53480584)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 2014

Language	Label	Description	Also known as
English	The global intellectual property landscape of induced pluripotent stem cell technologies.	scientific article published in August 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

The global intellectual property landscape of induced pluripotent stem cell technologies. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

intellectual property

0 references

author name string

MacKenna Roberts

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

Ivan B Wall

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

Ian Bingham

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

Dominic Icely

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

Brock Reeve

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

Kim Bure

6

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

Anna French

7

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

David A Brindley

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

publication date

1 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

Nature Biotechnology

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

32

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

8

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

742-748

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

Recalibrating intellectual property rights to enhance translational research collaborations

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

Access to stem cells and data: persons, property rights, and scientific progress.

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

Embryonic stem cell trials for macular degeneration: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

Induced pluripotent stem cell lines derived from human somatic cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

Patents and misplaced angst: lessons for translational stem cell research from genomics

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

Can patents deter innovation? The anticommons in biomedical research

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

Pluripotent patents make prime time: an analysis of the emerging landscape

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

No-fee university licenses spur biotech partnerships

1 reference

https://api.crossref.org/works/10.1038%2FNBT.2975

21 January 2018

Opening stem cell research and development: a policy proposal for the management of data, intellectual property, and ethics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25093884

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The gold rush for induced pluripotent stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25093884

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The global stem cell patent landscape: implications for efficient technology transfer and commercial development

1 reference

https://pubmed.ncbi.nlm.nih.gov/25093884

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Japan to offer fast-track approval path for stem cell therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25093884

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LULL(ed) into complacency: a perspective on licenses and stem cell translational science

1 reference

https://pubmed.ncbi.nlm.nih.gov/25093884

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NBT.2975

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/25093884

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53480584&oldid=2212146020"